Clinical Value of Neutrophil/Lymphocyte Ratio in Predicting Postoperative Complications and Prognosis in Patients with Colorectal Cancer Undergoing Surgical Treatment
Yıl: 2020 Cilt: 30 Sayı: 1 Sayfa Aralığı: 49 - 56 Metin Dili: İngilizce DOI: 10.4274/tjcd.galenos.2020.2019-11-5 İndeks Tarihi: 11-05-2021
Clinical Value of Neutrophil/Lymphocyte Ratio in Predicting Postoperative Complications and Prognosis in Patients with Colorectal Cancer Undergoing Surgical Treatment
Öz: Aim: Recently, the preoperative systemic inflammatory response has been reported to be a prognostic factor in patients with colorectal cancer (CRC). In this context, the preoperative neutrophil/lymphocyte ratio (NLR) has been proposed as a useful predictor of prognosis. In this study, we aimed to determine the clinical value and prognostic significance of neutrophil/lymphocyte ratio in predicting postoperative complications in patients undergoing surgical treatment for colorectal cancer.Method: Patients who underwent surgical treatment for colorectal cancer between 2015-2019 were included in the study. group 1 (Low NLR) and group 2 (High NLR) were formed. Demographic and clinical characteristics, intraoperative and postoperative results, and mean survival were compared. The value of NLR in predicting postoperative complications at the determined cut-off value was examined.Results: Patients were divided into two groups according to the cut-off value of 2.08. Group 1 consisted of 56 patients, and group 2 consisted of 223 patients. Male sex was dominant in both groups (60% vs 64%, p=0.349), while patients in group 2 received more neoadjuvant treatment (29.1% vs 12.5%, p=0.007). Intraoperative complication rates were similar (1.8% vs 4%, p=0.369), pathological grade (p=0.031), and stage (p=0.113) were similar. Postoperative complications were more common in group 2 (24.7% vs 10.7%, p=0.015). Total survival was shorter in group 2 (46 months vs. 52 months, p=0.025). At the determined cutoff value, NLR predicted postoperative complications with 22.94% specificity and 90.6% sensitivity.Conclusion: High NLR was associated with postoperative complications and survival. Although it has a prognostic value, its value in predicting postoperative complications is limited and cannot be used alone.
Anahtar Kelime: Nötrofil/Lenfosit Oranının Cerrahi Uygulanan Kolorektal Kanserli Hastalarda Postoperatif Komplikasyonları ve Prognozu Öngörebilmedeki Klinik Değeri
Öz: Amaç: Son zamanlarda, preoperatif sistemik enflamatuar yanıtın kolorektal kanserli hastalarda (CRC) prognostik bir faktör olduğu bildirilmiştir. Bu bağlamda preoperatif nötrofil lenfosit oranı (NLO), prognoz için faydalı bir öngörü faktörü olarak öne sürülmüştür. Bu çalışmada nötrofil/lenfosit oranının kolorektal kanser nedeniyle cerrahi tedavi uygulanan hastalarda postoperatif komplikasyonları öngörebilmedeki klinik değerini ve prognostik önemini saptamayı amaçladık. Yöntem: 2015-2019 yılları arasında kolorektal kanser nedeniyle cerrahi tedavi, uygulanan hastalar çalışmaya dahil edili. Grup 1 (NLO düşük) ve grup 2 (NLO yüksek) olmak üzere iki grup oluşturuldu. Gruplarda hastaların demografik ve klinik özellikleri intraoperatif ve postoperatif sonuçlarları ortalama sağkalımları karşılaştırıldı. NLO belirlenen cut off değerinde postoperatif komplikasyonları öngörebilmedeki değerine bakıldı. Bulgular: Hastalar 2,08 cut-off değerine göre iki gruba ayrıldı grup 1=56 hastadan grup 2=223 hastadan oluşuyordu Her iki grupta da erkek cinsiyet baskındı (%60 vs,%64 p=0,349), grup 2’deki hastalar daha çok neoadjuvant tedavi almıştı (%29,1 vs %12,5 p=0,007), intraoperatif komplikasyon oranları benzer (%1,8 vs %4 p=0,369), Patolojik grade p=0,031 ve evre p=0,131 benzerdi. Postoperatif komplikasyon grup 2’de daha sık görülmüştü (%24,7 vs %10,7 p=0,015) Toplam sağ kalım grup2’de daha kısa (46 ay vs 52 ay p=0,025) belirlenen cut-off değerinde NLO %22,94 spesifite ve %90,6 sensivite ile hastada postopertif komplikasyonu ön görüyordu. Sonuç: Yüksek NLO postoperatif komplikasyonlarla ve sağ kalımla ilişkiliydi. Prognostik değeri olmakla beraber postoperatif komplikasyonları tahmin etmedeki değeri kısıtlıdır ve tek başına kullanılamaz.
Anahtar Kelime: Belge Türü: Makale Makale Türü: Araştırma Makalesi Erişim Türü: Erişime Açık
- 1. Edwards BK, Ward E, Kohler BA, Eheman C, Zauber AG, Anderson RN, Jemal A, Schymura MJ, Lansdorp-Vogelaar I, Seeff LC, van Ballegooijen M, Goede SL, Ries LA. Annual report to the nation on the status of cancer, 1975-2006, featuring colorectal cancer trends and impact of interventions (risk factors, screening, and treatment) to reduce future rates. Cancer 2010;116:544-573.
- 2. Tsai PL, Su WJ, Leung WH, Lai CT, Liu CK. Neutrophil–lymphocyte ratio and CEA level as prognostic and predictive factors in colorectal cancer: A systematic review and meta-analysis. J Cancer Res Ther 2016;12:582-589.
- 3. Hanahan D, Weinberg RA. Hallmarks of cancer: the next generation. Cell 2011;144:646-674.
- 4. Roxburgh CS, McMillan DC. Role of systemic inflammatory response in predicting survival in patients with primary operable cancer. Future Oncol 2010;6:149-163.
- 5. McMillan DC. Systemic inflammation, nutritional status and survival in patients with cancer. Curr Opin Clin Nutr Metab Care 2009;12:223-226.
- 6. Kwon KA, Kim SH, Oh SY, Lee S, Han JY, Kim KH, Goh RY, Choi HJ, Park KJ, Roh MS, Kim HJ, Kwon HC, Lee JH. Clinical significance of preoperative serum vascular endothelial growth factor, interleukin-6, and C-reactive protein level in colorectal cancer. BMC Cancer 2010;10:203.
- 7. Maeda K, Shibutani M, Otani H, Nagahara H, Ikeya T, Iseki Y, Tanaka H, Muguruma K, Hirakawa K. Inflammation-based factors and prognosis in patients with colorectal cancer. World J Gastrointest Oncol 2015;7:111- 117.
- 8. Walsh SR, Cook EJ, Goulder F, Justin TA, Keeling NJ. Neutrophil lymphocyte ratio as a prognostic factor in colorectal cancer. J Surg Oncol 2005;91:181-184.
- 9. Halazun KJ, Aldoori A, Malik HZ, Al-Mukhtar A, Prasad KR, Toogood GJ, Lodge JP. Elevated preoperative neutrophil to lymphocyte ratio predicts survival following hepatic resection for colorectal liver metastases. Eur J Surg Oncol 2008;34:55-60.
- 10. Wei Y, Zhang X, Wang G, Zhou Y, Luo M, Wang S, Hong C. The impacts of pretreatment circulating eosinophils and basophils on prognosis of stage I–III colorectal cancer. Asia Pac J Clin Oncol 2018;14:e243-e251.
- 11. Li Z, Zhao R, Cui Y, Zhou Y, Wu X. The dynamic change of neutrophil to lymphocyte ratio can predict clinical outcome in stage I-III colon cancer. Sci Rep 2018;8:9453.
- 12. Mantovani A, Allavena P, Sica A, Balkwill F. Cancer-related infammation. Nature 2008;454:436-444.
- 13. Ueno H, Hawrylowicz CM, Banchereau J. Immunological intervention in human diseases. J Transl Med 2007;5:1-7.
- 14. Shau HY, Kim A. Suppression of lymphokine‑activated killer induction by neutrophils. J Immunol 1988;141:4395‑4402.
- 15. Galon J, Fridman WH, Pages F. The adaptive immunologicmicroenvironment in colorectal cancer: a novel perspective. Cancer Res 2007;67:1883-1886.
- 16. Goret NE, Goret CC, Topal U, Ozkan OF. A review of B lymphocytes in tumour immune response. J Stem Cell Res Med 2019;4:1-3.
- 17. Chiang SF, Hung HY, Tang R, Changchien CR, Chen JS, You YT, Chiang JM, Lin JR. Can neutrophil‑to‑lymphocyte ratio predict the survival of colorectal cancer patients who have received curative surgery electively? Int J Colorectal Dis 2012;27:1347‑1357.
- 18. Türker S, Karaçin C, İmamoğlu Gİ, Eren T, Esen R, Çılbır E, Altınbaş M, Yazılıtaş D. The relationship between localization and neutrophil lymphocyte ratio in colon carcinoma. Ortadoğu Tıp Dergisi 2018;10:64- 67.
- 19. Choi WJ, Cleghorn MC, Jiang H, Jackson TD, Okrainec A, Quereshy FA. Preoperative neutrophil-to-lymphocyte ratio is a better prognostic serum biomarker than platelet-to-lymphocyte ratio in patients undergoing resection for nonmetastatic colorectal cancer. Ann Surg Oncol 2015;22 Suppl 3:S603-613.
- 20. Kubo T, Ono S, Ueno H, Shinto E, Yamamoto J, Hase K. Impact of the perioperative neutrophil-to-lymphocyte ratio on the long-term survival following an elective resection of colorectal carcinoma. Int J Colorectal Dis 2014;29:1091-1099.
- 21. Shen J, Zhu Y, Wu W, Zhang L, Ju H, Fan Y, Zhu Y, Luo J, Liu P, Zhou N, Lu K, Zhang N, Li D, Liu L. Prognostic role of Neutrophil-to-Lymphocyte ratio in locally advanced rectal cancer treated with neoadjuvant chemoradiotherapy. Med Sci Monit 2017;23:315-324.
- 22. Sarbinowski R, Arvidsson S, Tylman M, Oresland T, Bengtsson A. Plasma concentration of procalcitonin and systemic inflammatory response syndrome after colorectal surgery. Acta Anaesthesiol Scand 2005;49:191- 196.
- 23. Cook EJ, Walsh SR, Farooq N, Alberts JC, Justin TA, Keeling NJ. Postoperative neutrophil–lymphocyte ratio predicts complications following colorectal surgery. Int J Surg 2007;5:27-30.
- 24. Caputo D, Caricato M, Coppola A, La Vaccara V, Fiore M, Coppola R. Neutrophil to lymphocyte ratio (NLR) and derived neutrophil to lymphocyte ratio (d-NLR) predict non-responders and postoperative complications in patients undergoing radical surgery after neo-adjuvant radio-chemotherapy for rectal adenocarcinoma. Cancer Invest 2016;34:440-451.
- 25. Nagarsheth N, Wicha MS, Zou W. Chemokines in the cancer microenvironment and their relevance in cancer immunotherapy. Nat Rev Immunol 2017;17:559-572.
- 26. Dimitriou N, Felekouras E, Karavokyros I, Alexandrou A, Pikoulis E, Griniatsos J. Neutrophils to lymphocytes ratio as a useful prognosticator for stage II colorectal cancer patients. BMC Cancer 2018;18:1202.
- 27. Ozdemir Y, Akin ML, Sucullu I, Balta AZ, Yucel E. Pretreatment neutrophil/ lymphocyte ratio as a prognostic aid in colorectal cancer. Asian Pac J Cancer Prev 2014;15:2647-2650.
| APA | YALAV O, Topal U, Unal A, eray i, Rencuzogullari A (2020). Clinical Value of Neutrophil/Lymphocyte Ratio in Predicting Postoperative Complications and Prognosis in Patients with Colorectal Cancer Undergoing Surgical Treatment. , 49 - 56. 10.4274/tjcd.galenos.2020.2019-11-5 |
| Chicago | YALAV Orçun,Topal Uğur,Unal Ayse Gizem,eray ismail cem,Rencuzogullari Ahmet Clinical Value of Neutrophil/Lymphocyte Ratio in Predicting Postoperative Complications and Prognosis in Patients with Colorectal Cancer Undergoing Surgical Treatment. (2020): 49 - 56. 10.4274/tjcd.galenos.2020.2019-11-5 |
| MLA | YALAV Orçun,Topal Uğur,Unal Ayse Gizem,eray ismail cem,Rencuzogullari Ahmet Clinical Value of Neutrophil/Lymphocyte Ratio in Predicting Postoperative Complications and Prognosis in Patients with Colorectal Cancer Undergoing Surgical Treatment. , 2020, ss.49 - 56. 10.4274/tjcd.galenos.2020.2019-11-5 |
| AMA | YALAV O,Topal U,Unal A,eray i,Rencuzogullari A Clinical Value of Neutrophil/Lymphocyte Ratio in Predicting Postoperative Complications and Prognosis in Patients with Colorectal Cancer Undergoing Surgical Treatment. . 2020; 49 - 56. 10.4274/tjcd.galenos.2020.2019-11-5 |
| Vancouver | YALAV O,Topal U,Unal A,eray i,Rencuzogullari A Clinical Value of Neutrophil/Lymphocyte Ratio in Predicting Postoperative Complications and Prognosis in Patients with Colorectal Cancer Undergoing Surgical Treatment. . 2020; 49 - 56. 10.4274/tjcd.galenos.2020.2019-11-5 |
| IEEE | YALAV O,Topal U,Unal A,eray i,Rencuzogullari A "Clinical Value of Neutrophil/Lymphocyte Ratio in Predicting Postoperative Complications and Prognosis in Patients with Colorectal Cancer Undergoing Surgical Treatment." , ss.49 - 56, 2020. 10.4274/tjcd.galenos.2020.2019-11-5 |
| ISNAD | YALAV, Orçun vd. "Clinical Value of Neutrophil/Lymphocyte Ratio in Predicting Postoperative Complications and Prognosis in Patients with Colorectal Cancer Undergoing Surgical Treatment". (2020), 49-56. https://doi.org/10.4274/tjcd.galenos.2020.2019-11-5 |
| APA | YALAV O, Topal U, Unal A, eray i, Rencuzogullari A (2020). Clinical Value of Neutrophil/Lymphocyte Ratio in Predicting Postoperative Complications and Prognosis in Patients with Colorectal Cancer Undergoing Surgical Treatment. Türk Kolon ve Rektum Hastalıkları Dergisi, 30(1), 49 - 56. 10.4274/tjcd.galenos.2020.2019-11-5 |
| Chicago | YALAV Orçun,Topal Uğur,Unal Ayse Gizem,eray ismail cem,Rencuzogullari Ahmet Clinical Value of Neutrophil/Lymphocyte Ratio in Predicting Postoperative Complications and Prognosis in Patients with Colorectal Cancer Undergoing Surgical Treatment. Türk Kolon ve Rektum Hastalıkları Dergisi 30, no.1 (2020): 49 - 56. 10.4274/tjcd.galenos.2020.2019-11-5 |
| MLA | YALAV Orçun,Topal Uğur,Unal Ayse Gizem,eray ismail cem,Rencuzogullari Ahmet Clinical Value of Neutrophil/Lymphocyte Ratio in Predicting Postoperative Complications and Prognosis in Patients with Colorectal Cancer Undergoing Surgical Treatment. Türk Kolon ve Rektum Hastalıkları Dergisi, vol.30, no.1, 2020, ss.49 - 56. 10.4274/tjcd.galenos.2020.2019-11-5 |
| AMA | YALAV O,Topal U,Unal A,eray i,Rencuzogullari A Clinical Value of Neutrophil/Lymphocyte Ratio in Predicting Postoperative Complications and Prognosis in Patients with Colorectal Cancer Undergoing Surgical Treatment. Türk Kolon ve Rektum Hastalıkları Dergisi. 2020; 30(1): 49 - 56. 10.4274/tjcd.galenos.2020.2019-11-5 |
| Vancouver | YALAV O,Topal U,Unal A,eray i,Rencuzogullari A Clinical Value of Neutrophil/Lymphocyte Ratio in Predicting Postoperative Complications and Prognosis in Patients with Colorectal Cancer Undergoing Surgical Treatment. Türk Kolon ve Rektum Hastalıkları Dergisi. 2020; 30(1): 49 - 56. 10.4274/tjcd.galenos.2020.2019-11-5 |
| IEEE | YALAV O,Topal U,Unal A,eray i,Rencuzogullari A "Clinical Value of Neutrophil/Lymphocyte Ratio in Predicting Postoperative Complications and Prognosis in Patients with Colorectal Cancer Undergoing Surgical Treatment." Türk Kolon ve Rektum Hastalıkları Dergisi, 30, ss.49 - 56, 2020. 10.4274/tjcd.galenos.2020.2019-11-5 |
| ISNAD | YALAV, Orçun vd. "Clinical Value of Neutrophil/Lymphocyte Ratio in Predicting Postoperative Complications and Prognosis in Patients with Colorectal Cancer Undergoing Surgical Treatment". Türk Kolon ve Rektum Hastalıkları Dergisi 30/1 (2020), 49-56. https://doi.org/10.4274/tjcd.galenos.2020.2019-11-5 |
